Comprehensive Treatment Module for Medically Unexplained Physical Symptoms – A Guide for General Practitioners

Goel, Aditya; Ranjan, Piyush; Klanidhi, Kamal Bandhu; Deb, Koushik Sinha; Sarkar, Siddharth; Kaur, Tanveer; Sahu, Anamika; Baitha, Upendra; Chakrawarty, Avinash; Kumar, Arvind

doi:10.7759/cureus.16263

Cited by 3 publications

(2 citation statements)

References 27 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…These insights underscore the necessity for locally tailored evaluation modules, recognizing the distinct symptom presentations in Indian populations compared to the West [24,25]. In response, certain researchers have formulated comprehensive treatment modules, coupled with yoga therapy, to address the needs of these patients effectively [26,27].…”

Section: Discussionmentioning

confidence: 99%

Evaluation of Tools to Assess Symptoms and Symptom Severity in Patients With Medically Unexplained Physical Symptoms: A Systematic Review and Narrative Synthesis

Kuanar Baboo,

Ranjan,

Kaur

et al. 2024

Cureus

Self Cite

View full text Add to dashboard Cite

A substantial portion of patients presenting to healthcare settings exhibit physical symptoms lacking clear, demonstrable organic causes. Accurate assessment of symptom severity is crucial for documenting outcomes and establishing treatment efficacy. This systematic review and narrative synthesis aims to provide researchers with insights into available and validated tools for assessing medically unexplained physical symptoms (MUPS). It involved comprehensive searches across electronic databases, including PubMed, Wiley, and Cochrane, adhering to PRISMA and COSMIN guidelines. The study comprised two phases: Phase 1 systematically reviewed tools for assessing MUPS symptoms and severity, while Phase 2 conducted a narrative synthesis of their measurement properties, focusing on validity and reliability. Out of 14,459 records, 191 articles were identified, leading to the recognition of 16 validated tools for assessing MUPS symptoms and severity. Most tools demonstrated excellent internal consistency and structural validity. However, the majority lacked cross-cultural validity. The choice of tools for the assessment of MUPS will assist clinicians and researchers in determining the severity of MUPS and developing a tailored treatment plan to improve the physical and psychological functioning of these patients.

show abstract

Section: Discussionmentioning

confidence: 99%

Evaluation of Tools to Assess Symptoms and Symptom Severity in Patients With Medically Unexplained Physical Symptoms: A Systematic Review and Narrative Synthesis

Kuanar Baboo,

Ranjan,

Kaur

et al. 2024

Cureus

Self Cite

View full text Add to dashboard Cite

show abstract

“…Various long COVID-19 symptoms can be mitigated using tools that have previously been shown to be effective for children with medically unexplained symptoms, such as biofeedback, cognitive behavioral therapy, breathing exercises, and activity pacing. 85,86 It is also very important to note that for some children, it can take months for them to feel better. While mental health problems may not be the primary driver of the long COVID-19 symptoms, they can complicate and further delay recovery if present and not properly addressed.…”

Section: Treatmentmentioning

confidence: 99%

Clinical Epidemiology of Pediatric Coronavirus Disease 2019 and its Postacute Sequelae

Habet

Oliveira

2023

Semin Respir Crit Care Med

View full text Add to dashboard Cite

The coronavirus disease 2019 (COVID-19) pandemic has affected individuals of all ages across. Although children generally experience a benign illness from COVID-19, the emergence of novel variants of the virus has resulted in significant changes in the morbidity and mortality rates for this age group. Currently, COVID-19 is the eighth leading cause of pediatric deaths in the United States. In addition to acute respiratory illness, some children can develop a severe postinfectious condition known as a multisystem inflammatory syndrome in children, which can progress to rapid-onset cardiogenic shock. Recovery from COVID-19 can also be slow for some children, resulting in persistent or reoccurring symptoms for months, commonly referred to as long COVID. These postinfectious sequelae are often distressing for children and their parents, can negatively impact the quality of life, and impose a considerable burden on the health care system. In this article, we review the clinical epidemiology of pediatric COVID-19 and outline the management considerations for its acute and postacute manifestations.

show abstract

Exploring the Link Between Somatic and Psychiatric Symptoms in Patients With Medically Unexplained Physical Symptoms: A Cross-Sectional Survey From North India

Pallati,

Singh,

Ranjan

et al. 2024

Cureus

View full text Add to dashboard Cite

Background: The association between somatic symptoms and psychiatric co-morbidities remains unexplored among patients with medically unexplained physical symptoms (MUPS) in Asian populations. This study aims to bridge this gap by investigating psychiatric morbidities and their determinants among patients presenting with MUPS in an Indian setup. Methodology: This cross-sectional study, conducted in the outpatient department (OPD) of a tertiary care hospital in India, assessed 200 patients diagnosed with MUPS. Assessment tools, such as the Somatic Symptom Scale (SSS-8), Presumptive Stressful Life Event Scale (PSLES), and Depression, Anxiety, and Stress Scale (DASS), were administered to collect data. Results: The study examined patients (mean age 36.51±9.82 years), predominantly comprising females (67.5%), presenting with MUPS. Common presenting symptoms were general (96.3%), musculoskeletal pain (91.7%), and gastrointestinal symptoms reported by 81.7%. Medium somatic symptom severity (57%) was more prevalent in females. Prevalent psychiatric co-morbid conditions included depression (mild: 22.0%, moderate: 26.5%), moderate anxiety (41.5%), and moderate stress (26%). Strong associations were observed between the SSS-8 score and depression (χ²(6, N = 200) = 49.26, p < 0.001), anxiety (χ²(8, N = 200) = 37.90, p < 0.001), stress (χ²(6, N = 200) = 44.45, p < 0.001), and the experience of stressful life events (χ²(3, N = 200) = 6.5, p < 0.05). Conclusion: The study indicates an intertwined association between MUPS and psychiatric disorders. Individuals with MUPS commonly experience heightened anxiety and depression, emphasizing the complex interplay between somatic symptoms and emotional well-being. Consideration of environmental and social factors may be crucial for a comprehensive understanding.

show abstract

Comprehensive Treatment Module for Medically Unexplained Physical Symptoms – A Guide for General Practitioners

Cited by 3 publications

References 27 publications

Evaluation of Tools to Assess Symptoms and Symptom Severity in Patients With Medically Unexplained Physical Symptoms: A Systematic Review and Narrative Synthesis

Evaluation of Tools to Assess Symptoms and Symptom Severity in Patients With Medically Unexplained Physical Symptoms: A Systematic Review and Narrative Synthesis

Clinical Epidemiology of Pediatric Coronavirus Disease 2019 and its Postacute Sequelae

Exploring the Link Between Somatic and Psychiatric Symptoms in Patients With Medically Unexplained Physical Symptoms: A Cross-Sectional Survey From North India

Contact Info

Product

Resources

About